PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers tested an asthma drug for treating alcoholism. It failed except with this group

Ongoing analyses of this clinical trial is needed

2025-06-02
(Press-News.org) Key takeaways

Ibudilast is a drug approved in Japan for the treatment of asthma and post-stroke dizziness by targeting inflammation; previous research suggested it could also help people reduce their drinking.  A UCLA clinical trial, however, has now shown that ibudilast worked no better than a placebo for trial participants in reducing alcohol consumption, although it did have a positive effect on women. Women tend to have higher levels of inflammation than men, and the results of ibudilast testing with women point toward the role that inflammation may play in alcohol use disorder. A drug that once showed promise as a treatment for alcohol use disorder did not work as expected, a new UCLA clinical trial found. 

The drug, ibudilast, is approved for the treatment of asthma and post-stroke dizziness in Japan, and previous research suggested it might also help people reduce their drinking. The findings, published in the journal JAMA Network Open, showed that ibudilast works no better than a placebo for most people, although it did have a positive effect for one group of study participants.

“While ibudilast was not superior to the placebo, we saw that some individuals did better and some did worse with the drug,” said UCLA psychology professor and the study’s first author, Lara Ray. “Female study participants did better, but both men and women who came in with higher levels of depression did worse, which are results we can use to guide further research.”

The findings are the culmination of many years of investigation into ibudilast by Ray’s research group, the UCLA Addictions Lab. Although the drug did not turn out to be as effective as they had hoped, the mixed results nonetheless point toward the roles that inflammation and the immune system may play in alcoholism. Like apremilast, another drug undergoing testing as a potential alcoholism treatment, ibudilast targets immune responses and related inflammation.

“We think that there’s a strong immune contribution to psychiatric disorders, especially depression and alcohol use disorder,” said Ray. “Women generally have higher inflammation levels, and the fact that ibudilast works better for them and worse for people with more depressive symptoms suggests that we may be on the right track. Immune treatments have revolutionized cancer treatment, and we’re using this novel approach to do that for alcohol use disorder.”

For the study, the researchers recruited 102 adults who were seeking treatment for moderate or severe alcohol use disorder to take either ibudilast or a placebo twice daily for 12 weeks and followed up with them for four weeks after the treatment period ended. They tracked the percentage of heavy drinking days, the number of drinks per drinking day, and the percentage of days abstinent. Depressive symptoms and inflammation were also tracked.

“What we found is that there were general reductions in drinking across both the ibudilast and the placebo groups,” said Ray.

On average, participants started with seven drinks per drinking day, and by the end of treatment, they had reduced that to around three to four drinks per drinking day, on average. However, this reduction was seen in the placebo group and the ibudilast group, which means that the researchers couldn’t establish that ibudilast was superior to the placebo in reducing drinking. 

“One of the challenges in alcohol use disorder trials is that all participants usually improve their drinking across the board. Participants are responding to the whole treatment setting, and regardless of medication, we see a very pronounced beneficial effect on alcohol use disorder. So it can be hard to tease apart the placebo effect from the medication,” said Ray. 

Women who took ibudilast, however, drank fewer drinks per drinking day. The effect was strong enough that the researchers concluded that further studies testing the efficacy of ibudilast in reducing drinking for women are worthwhile. On the other hand, people who started the study with more depressive symptoms both drank fewer drinks per day and had more abstinent days while taking the placebo. Ibudilast also did not reduce markers of inflammation.

“Our lab is uncovering novel treatments for substance use disorders, and we’re excited that all the people who came into our study improved,” said Ray. “One of the challenges going forward is to follow people a little bit longer, say, in a six-month trial, so that we can get more of a separation between the treatment context and the active medication effect.” 

“Ongoing analyses of this clinical trial will help us elucidate who responds to this medication for alcohol use disorder, such as individuals reporting co-occurring pain and those with higher levels of inflammation to begin with.”

This trial was funded by the National Institute on Alcohol Abuse and Alcoholism, and the UCLA Addiction Lab’s ongoing trials will require a continued funding commitment from the federal government to develop effective new treatments for a problem that affects nearly 30 million adults in the United States alone.

“People are coming to our lab because they trust UCLA,” said Ray. “They’re reporting on their drinking regularly, and that, in and of itself, is causing pretty significant changes in their behavior.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Set it and forget it: Autonomous structures can be programmed to jump days in advance

2025-06-02
Researchers have created dynamic structures that leap into the air on a predetermined schedule without intervention from computers or external stimuli. Precisely when these “metashells” jump, and how high they jump, is engineered into the physical structure of the materials. “There are structures that ‘jump’ immediately when loading is removed – such as when a coiled spring is released,” says Jie Yin, corresponding author of a paper on the work and an associate professor of mechanical engineering at North Carolina State University. “We wanted to create a structure that does not rely on external stimuli and allows us to dictate the timing ...

Iron from coal, steel industries alters North Pacific ecosystem

2025-06-02
Along with nutrients like nitrogen and phosphorus, iron is essential for the growth of microscopic phytoplankton in the ocean. However, a new study led by oceanographers at the University of Hawai‘i (UH) at Mānoa revealed that iron released from industrial processes, such as coal combustion and steel making, is altering the ecosystem in the North Pacific Transition Zone, a region just north of Hawai‘i that is important for fisheries in the Pacific. The study was published today in the Proceedings of the National Academy of Sciences USA. “This ...

Canadian researcher receives funding from ARIA to unlock potential of plants

2025-06-02
Imagine a world where crops can thrive regardless of climate or disease and provide all the essential nutrients our bodies need. Researchers at Western University’s Schulich School of Medicine & Dentistry are now part of a U.K.-based initiative to explore that very possibility.   The Advanced Research + Invention Agency (ARIA), the U.K.’s research and development funding agency, announced June 2 that Schulich Medicine & Dentistry professor Bogumil Karas has been named ...

Visionary support from Veale Foundation will establish university hospitals Veale Healthcare Transformation Institute

2025-06-02
CLEVELAND – A new visionary gift from the Veale Foundation will establish the University Hospitals Veale Healthcare Transformation Institute. The $23.5 million in support represents an investment in University Hospitals’ value-based care initiatives. Peter J. Pronovost, MD, PhD, UH Chief Quality and Clinical Transformation Officer, will serve as the institute’s founding and first president. “Healthcare today tells a story of scarcity – it harms too often, costs too much and learns and ...

Investigating cocaine addiction using fruit flies

2025-06-02
In a new JNeurosci paper, Adrian Rothenfluh and colleagues from the University of Utah developed a fruit fly model of cocaine self-administration that can be used to explore the genetic underpinnings of cocaine addiction.   To model voluntary cocaine intake in fruit flies, or Drosophila melanogaster, the researchers first assessed cocaine consumption and preferences of this insect. Cocaine was innately aversive to fruit flies because it activated their bitter-sensing receptors. In other words, the fruit flies did not like cocaine’s ...

Fruit flies on cocaine could reveal better therapies for addiction

2025-06-02
For the first time, researchers have created genetically modified fruit flies that can become addicted to cocaine. The flies will self-administer cocaine if given the option. The new model could prove immensely valuable for the development of new therapies to prevent and treat cocaine use disorder, a growing and deadly concern that affects about 1.5 million people nationwide. Heredity strongly impacts the risk of developing cocaine use disorder, but the large number of genes implicated in addiction risk has made it difficult to determine which might be the best targets for therapeutics. With their new fruit fly model ...

New data shows MMR vaccination rate decline across US

2025-06-02
A new county-level dataset from Johns Hopkins University researchers reveals a national decline in the measles-mumps-rubella (MMR) vaccination rate among U.S. children since the start of the COVID-19 pandemic. Out of 2,066 studied counties, 1,614 counties, 78%, reported drops in vaccinations and the average county-level vaccination rate fell 93.92% pre-pandemic to 91.26% post-pandemic—an average decline of 2.67%, moving further away from the 95% herd immunity threshold to predict or limit the spread of measles. Only four of the 33 states in studied—California, ...

Clinical validation of a circulating tumor DNA–based blood test to screen for colorectal cancer

2025-06-02
About The Study: In an average-risk colorectal cancer screening population, a blood-based test demonstrated acceptable accuracy for colorectal cancer detection, but detection of advanced precancerous lesions remains a challenge, and ongoing efforts are needed to improve test sensitivity.  Corresponding Author: To contact the corresponding author, Theodore R. Levin, MD, email theodore.levin@kp.org. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2025.7515) Editor’s Note: Please see the article for additional ...

Screening colonoscopy yields among adults ages 45 to 49 after lowering the colon cancer screening age

2025-06-02
About The Study: The finding of a slightly lower prevalence of any adenoma in the younger compared with the older age group (35.4% vs 40.8%) in the current study is consistent with an evaluation of 2001 screening colonoscopies from a university-based medical center between 2019 and 2021, which reported slightly lower rates of adenoma detection in those ages 45 to 49 vs 50 to 54 (34.3% vs 38.2%) and with a large study of adenoma detection rates in those ages 45 to 49 vs 50 to 54 (28.6% vs 31.8%) who underwent a screening colonoscopy before the change in guidelines ...

Trends in county-level MMR vaccination coverage in children in the United States

2025-06-02
About The Study: This county-level dataset complements the state and national-level Centers for Disease Control and Prevention data, confirming a widespread decline in measles-mumps-rubella (MMR) vaccination rates in the U.S. after the COVID-19 pandemic while revealing significant heterogeneity in vaccination patterns within and across states. This dataset can be used in spatial and statistical analyses to identify factors associated with low or declining MMR rates in U.S. counties and help inform targeted vaccination strategies to reduce the risk of measles outbreaks.  Corresponding Author: To contact the corresponding author, Lauren M. ...

LAST 30 PRESS RELEASES:

Advancing regenerative agriculture: TUdi unveils new digital tools for soil health monitoring

More staff addressing mental health in schools buffers toll of growing up in disadvantaged communities

Still top cause of death, the types of heart disease people are dying from is changing

Scientists detect deep Earth pulses beneath Africa

As fewer Americans die from heart attacks, more succumb to chronic heart disease

Guidance issued for GPs managing weight-loss injection patients

Low-cost carbon capture? Bury wood debris in managed forests

Scientists unravel mystery of Mycetoma grain formation

Exposure to particulate matter during pregnancy is associated with an increased risk of childhood obesity

How a propolis compound with health benefits interacts with cell membranes: Study reveals nymphaeol a in action

Flawed impact metrics jeopardize EU deregulation plans, study finds

New study calls for rethink on alcohol policy

New Danish research centre to make designed proteins with vast potential

Thin-film research enters new era with innovative AI approach

Smart amplifier enabler for more qubits in future quantum computers

Following the tracks of an extremely adaptive bacterium

New ‘designer drugs’ pose growing threat to road safety in the US

Tackling depressive symptoms in high school students by honing emotional and social skills

One in five US foods and drinks contain synthetic dyes, study shows

One in five packaged foods and drinks sold in the United States contains synthetic dyes, study shows

Large global study links severe bleeding after childbirth to increased risk of cardiovascular disease

Breaking the silence about men breaking bones

More sex, less pain and irritation for perimenopausal and postmenopausal women

New review highlights histone and non-histone lysine lactylation: From molecular mechanisms to therapeutic frontiers

Boson sampling finds first practical applications in quantum AI

Add a twist to π-molecules! A new design strategy for organic semiconductor materials

Bushfire evacuation simulator wins prestigious US prize

Desert lichen offers new evidence for the possibility of life on other planets

Researchers reveal how brain amplifies perception of pain from multiple sources

The first “SpongeBooster of the Year” award celebrates efforts in wetland restoration

[Press-News.org] Researchers tested an asthma drug for treating alcoholism. It failed except with this group
Ongoing analyses of this clinical trial is needed